Does aBCG2 impair the activity of the aurora kinase inhibitor tozasertib but not of alisertib?
Tozasertib but not alisertib activity is affected by ABCG2 expression. This should be considered within the design and analysis of experiments and clinical trials investigating these compounds.
We demonstrate the occurrence of ITS 16S-23S rRNa polymorphisms within single Frankia strains.